CX CX
Company Profile ↓Company Overview
CX (CX) is a publicly traded company listed on with a market capitalization of $502.71B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Trades at an undemanding P/E of 17.7.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $16.13B (+0.4% YoY); net profit $960.00M.
- Trailing 12 Months Year-on-year growth — revenue +0.4%, earnings +2.2%.
- 5-Year Trend Long-term compounding — revenue CAGR 3.1%, profit CAGR 3.8%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 3.13% |
| 1 Year: | 0.43% |
Compounded Profit Growth
| 5 Years: | 3.82% |
| 1 Year: | 2.24% |
Stock Price Performance
| 1 Year: | +41.32% |
| 6 Months: | -9.00% |
| 3 Months: | -10.04% |
| 1 Month: | -4.62% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)36.51 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 4.09B | 4.25B | 4.18B | 4.02B | 4.59B |
| Cost of Revenue | - | 2.69B | 2.82B | 2.82B | 2.70B | 2.98B |
| Gross Profit | - | 1.40B | 1.43B | 1.36B | 1.32B | 1.62B |
| Operating Expenses | - | 903.67M | 878.31M | 906.26M | 867.00M | 937.35M |
| Operating Income | - | 494.52M | 547.33M | 456.92M | 453.00M | 680.64M |
| EBITDA | - | 615.11M | 532.73M | 29.23M | 776.00M | 666.07M |
| Interest Expense | - | 120.53M | 110.15M | 147.28M | 110.00M | 101.70M |
| Pretax Income | - | 435.07M | 360.78M | -182.70M | 325.00M | 495.41M |
| Tax Provision | - | 99.91M | 120.87M | 112.47M | 94.00M | 139.73M |
| Net Income | - | 318.02M | 263.70M | -355.68M | 228.00M | 346.64M |
| Diluted EPS | - | 2.20 | 5.40 | -0.25 | 0.16 | 2.40 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 14.71B | 16.40B | 16.06B | 16.13B |
| Cost of Revenue | - | 10.22B | 10.87B | 10.65B | 10.82B |
| Gross Profit | - | 4.49B | 5.54B | 5.41B | 5.31B |
| Operating Expenses | - | 3.12B | 3.59B | 3.58B | 3.52B |
| Operating Income | - | 1.36B | 1.95B | 1.82B | 1.79B |
| EBITDA | - | 2.17B | 3.07B | 2.81B | 2.57B |
| Interest Expense | - | 533.00M | 573.00M | 585.00M | 493.00M |
| Pretax Income | - | 570.00M | 1.33B | 991.00M | 789.00M |
| Tax Provision | - | 168.00M | 1.21B | 67.00M | 385.00M |
| Net Income | - | 858.00M | 182.00M | 939.00M | 960.00M |
| Diluted EPS | - | 0.58 | 0.12 | 0.64 | 0.65 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 26.45B | 28.43B | 27.30B | 28.95B |
| Current Assets | - | 4.53B | 5.00B | 5.02B | 6.10B |
| Cash & Equivalents | - | 495.00M | 624.00M | 864.00M | 1.82B |
| Inventory | - | 1.67B | 1.79B | 1.49B | 1.53B |
| Receivables | - | 1.64B | 1.75B | 1.58B | 1.77B |
| Total Liabilities | - | 15.54B | 16.32B | 14.82B | 15.31B |
| Current Liabilities | - | 5.55B | 6.79B | 6.09B | 7.35B |
| Long Term Debt | - | 6.92B | 6.20B | 5.34B | 4.46B |
| Total Debt | - | 8.82B | 7.49B | 6.70B | 6.78B |
| Total Equity | - | 10.50B | 11.76B | 12.18B | 13.33B |
| Shares Outstanding | - | 44.19B | 43.47B | 43.52B | 43.52B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 1.37B | 2.29B | 1.98B | 1.98B |
| Investing Cash Flow | - | -640.00M | -1.34B | -328.00M | -197.00M |
| Financing Cash Flow | - | -961.00M | -701.00M | -1.25B | -796.00M |
| Capital Expenditure | - | -906.00M | -1.06B | -1.28B | -1.21B |
| Free Cash Flow | - | 462.00M | 1.23B | 696.00M | 763.00M |
| Net Change in Cash | - | -233.00M | 245.00M | 398.00M | 982.00M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 30.5% | 33.7% | 33.7% | 32.9% |
| Operating Margin % | - | 9.3% | 11.9% | 11.3% | 11.1% |
| Net Margin % | - | 5.8% | 1.1% | 5.8% | 6.0% |
| ROE % | - | 8.2% | 1.5% | 7.7% | 7.2% |
| ROCE % | - | 6.5% | 9.0% | 8.6% | 8.3% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CX
CX Institutional Has $5.25 Million Stock Position in Cognizant Technology Solutions Corporation $CTSH - MarketBeat
<a href="https://news.google.com/rss/articles/CBMi8AFBVV95cUxObTVZcjJvQ19NS1pUYUp6emJvMzdaODBHck9CZlhnWVVZT1Jtd0ViNjFkdDFFQnEwNi1yTjVNcnNBVkl5REk3X0tMNVFvdXRQMDllS1BMQWFNWXhKZ1BJbTRmLVpldzVQZDBkSGtEOHE2MGhoVml1RGU1RzdkTG1hVl9oRzZfX0kta09kST…
Currys Turns Nearly Six Million Customer Interactions Into Actionable Insights - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxNdVNGcjB5TTJ5WDhiU1JtbW1URjRBb05sZkNkc0czMzV4eHRIMHk3Z3ZZaWZYT2Y4OWxWVTlscjczRTEzNnI1d01DUVJOU2VBQVBlWTRjYzhXLUVTMmI5QmZCNnFRLURCTnRtU2ZLVUg4UEFzNFBYQU9oMGRlRDBpY3hGcXhoQzhKYUNhTD…
2027 could be one of the best years for the stock market, says Fundstrat's Tom Lee - CNBC
<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxPa256a3dRZF9vTEhTcVpSRkdUX3c2V1B5dmxLbmRSS2YtVngtaElXM2Z4QVhIMWNzNWNPLWlORW1lRHAtSTN1YUhWM0Q4MTJpVWlNTmtvenpNQjJMSDdJeks1MHFUd2xvNmdGbE9CdUx2UWtSSk9iTk1XQXFJcXNBSDVReGxQT01pb084T2…
CX Institutional Purchases 4,197 Shares of Meta Platforms, Inc. $META - MarketBeat
<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxOSnhtOC1OWkdHdHhnVlZNVFNxRHRQMFNBSF9ObGNOaVZYZmw3RHd3Q2NITlcyd0E5d0l0aXozbmJQQWxXWmsyZUZhYlpzSWJCRk93ZzlhV3NIcm5WRmFBQUlfUDJVcHNPOFlSUm9Kbkp6Qk9nSVVwMTd5NE5FNGxlZDJLSkx6c1BQMEMxV1…
3 Reasons Growth Investors Will Love Cemex (CX) - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxPSU1lOTMtcVVoYWZLZl9qbTdURTVkSDV3bHVpaURTaDhzYm44VEJzcnN1V1JMM3Z4dVg3NzVwU1A4ejdEUUVzRW84Y0JlOEJDR25NVzZHcUdBSm1NVExjSFI1NWVzN3dmU3oyLWc2ajRFNzNTQzFROGY2aUZxU2RlMTU2N0ROVEZfX1ctSW…
Cemex S.A.B. de C.V. (CX) Releases Q1 2026 Earnings: Revenue Up 14.5% but Net Income Falls 68.1% - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMi1gFBVV95cUxPelVIWWRUS1pkSVcxV25LUV9vUDluMGVoTElRMVNsNnNibThKV3FPODZXazlGakZFTmtFV2xaRmNZMnVfVTdBZjkyajFqMG1TMlliWURkenJXTUNjeUVCR3VWTDNmX1dKdDdUR0tjOVFQZndkX01TR1cxT1JiNHRWVlNwc3NWdm9GQzN4bX…
CX — Frequently Asked Questions
What is the current share price of CX?
As of 2026-08-05 17:25 PDT, CX trades at $11.55 on NASDAQ/NYSE. Its 52-week range is $8.17 to $13.52.
What is the market capitalisation of CX?
CX has a market capitalisation of $502.71B on NASDAQ/NYSE.
What is the P/E ratio of CX?
CX trades at a trailing price-to-earnings (P/E) ratio of 17.66. Its price-to-book (P/B) ratio is 37.71.
What is the return on equity (ROE) of CX?
CX has a return on equity (ROE) of 7.20%. Its return on capital employed (ROCE) is 8.28%.
Is CX a good stock to buy?
This page provides a data-driven analysis of CX, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.